Edit Content
Register Now
Log In
Edit Content
Register Now
Log In
Log In
Register Now

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market

Leave a Comment / By /

U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market.  

Leave a Reply

Your email address will not be published. Required fields are marked *

Markets
Trading
About Us
Contact Us

Sign Up For Real Ac.